458 related articles for article (PubMed ID: 18666431)
21. Synthesis and anticonvulsant activity of new 6-methyl-1-substituted-4,6-diazaspiro[2.4]heptane-5,7-diones.
He X; Qiu G; Yang J; Xiao Y; Wu Z; Qiu G; Hu X
Eur J Med Chem; 2010 Sep; 45(9):3818-30. PubMed ID: 20542603
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vivo anticonvulsant activity of 2-methyl-2-[3-(5-piperazin-1-yl-[1,3,4]oxadiazol-2-yl)-phenyl]-propionitrile derivatives.
Harish KP; Mohana KN; Mallesha L; Veeresh B
Arch Pharm (Weinheim); 2014 Apr; 347(4):256-67. PubMed ID: 24395602
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anticonvulsant activity of some novel fused heterocyclic 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives.
Husain A; Naseer MA; Sarafroz M
Acta Pol Pharm; 2009; 66(2):135-40. PubMed ID: 19719046
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.
Rai NP; Narayanaswamy VK; Shashikanth S; Arunachalam PN
Eur J Med Chem; 2009 Nov; 44(11):4522-7. PubMed ID: 19640616
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anticonvulsant activity of 5-phenyl-[1,2,4]-triazolo[4,3-a]quinolines.
Guan LP; Jin QH; Wang SF; Li FN; Quan ZS
Arch Pharm (Weinheim); 2008 Dec; 341(12):774-9. PubMed ID: 19006091
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, anticonvulsant and neurotoxicity evaluation of 5-carbomethoxybenzoxazole derivatives.
Siddiqui N; Sarafroz M; Alam MM; Ahsan W
Acta Pol Pharm; 2008; 65(4):449-55. PubMed ID: 19051586
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antimicrobial studies of a new series of 2-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]-5-substituted-1,3,4-oxadiazoles.
Gaonkar SL; Rai KM; Prabhuswamy B
Eur J Med Chem; 2006 Jul; 41(7):841-6. PubMed ID: 16616395
[TBL] [Abstract][Full Text] [Related]
28. Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents.
Kaushik D; Khan SA; Chawla G
Eur J Med Chem; 2010 Sep; 45(9):3960-9. PubMed ID: 20573424
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole.
Amnerkar ND; Bhusari KP
Eur J Med Chem; 2010 Jan; 45(1):149-59. PubMed ID: 19853976
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and anticonvulsant activity evaluation of some 1,4-dihydropyridines and 3,5-(substituted)oxycarbonyl-1,4-dihydro-2,6-dimethyl-N-[2-(4-sulfamoylphenylamino)-acetyl]-4-(substituted)pyridines.
Subudhi BB; Panda PK; Swain SP; Sarangi P
Acta Pol Pharm; 2009; 66(2):147-53. PubMed ID: 19719048
[TBL] [Abstract][Full Text] [Related]
31. Anticonvulsant and monoamine oxidase inhibitory activity of substituted oxadiazol-thiones.
Tripathi S; Ahmad S; Barthwal JP; Tangri KK; Bhargava KP
Indian J Physiol Pharmacol; 1982; 26(2):113-8. PubMed ID: 7141616
[TBL] [Abstract][Full Text] [Related]
32. Some novel anticonvulsant agents derived from phthalazinedione.
Zayed MF; Ayyad RR
Arzneimittelforschung; 2012 Nov; 62(11):532-6. PubMed ID: 22956351
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.
Obniska J; Chlebek I; Pichór J; Kopytko M; Kamiński K
Acta Pol Pharm; 2009; 66(6):639-47. PubMed ID: 20050528
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of antimicrobial and anticonvulsant activities of some new 3-[2- (5-aryl-1,3,4-oxadiazol-2-yl/4-carbethoxymethylthiazol-2-yl) imino-4-thiazolidinon-5-ylidene]-5-substituted/nonsubstituted 1H-indole-2-ones and investigation of their structure-activity relationships.
Altintaş H; Ateş O; Uyde-Doğan BS; Alp FI; Kaleli D; Ozdemir O; Birteksöz S; Otük G; Atana D; Uzun M
Arzneimittelforschung; 2006; 56(3):239-48. PubMed ID: 16618017
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and in-vivo pharmacological screening of N,3-(substituted diphenyl)-5-phenyl-1H-pyrazoline-1-carbothioamide derivatives.
Siddiqui N; Alam P; Ahsan W
Arch Pharm (Weinheim); 2009 Mar; 342(3):173-81. PubMed ID: 19194967
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 2-substituted-6-(4H-1,2,4-triazol-4-yl)benzo[d]oxazoles as potential anticonvulsant agents.
Wei CX; Guan LP; Jia JH; Chai KY; Quan ZS
Arch Pharm Res; 2009 Jan; 32(1):23-31. PubMed ID: 19183873
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP
Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticonvulsant activity of new N-(alkyl/sub-stituted aryl)-N'-[4-(5-cyclohexylamino)-1,3,4-thiadiazole-2-yl)phenyl]thioureas.
Karakus S; Koçyiğit-Kaymakcioğlu B; Toklu HZ; Aricioglu F; Rollas S
Arch Pharm (Weinheim); 2009 Jan; 342(1):48-53. PubMed ID: 19035387
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of anticonvulsant and antimicrobial activities of 3-hydroxy-6-methyl-2-substituted 4h-pyran-4-one derivatives.
Aytemir MD; Caliş U; Ozalp M
Arch Pharm (Weinheim); 2004 May; 337(5):281-8. PubMed ID: 15095421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
